Integra LifeSciences announced that Jan De Witte has informed the Board of Directors of his intention to retire from his position as president and CEO of Integra following the appointment of a successor, which the company expects to occur by the end of 2024. The company also announced that Stuart Essig, Integra’s chairman, has been appointed to the role of executive chairman, effective immediately. The Board has initiated a formal search for a new president and CEO and engaged Heidrick & Struggles to support the Board in identifying a highly-qualified candidate with a track record of industry leading profitability and growth and the development of inspired, high-performing teams.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IART:
- Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
- Integra LifeSciences Announces Leadership Transition Plan
- Is IART a Buy, Before Earnings?
- Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
- Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
